ECNS - ETF AI Analysis
Top Page
iShares MSCI China Small-Cap ETF (ECNS)
Rating:57Neutral
Price Target:―
Positive Factors
Strong Year-To-Date Performance
The fund has delivered positive returns so far this year, showing improving momentum after recent ups and downs.
Solid Top Holdings Performance
Many of the largest positions, including several health care and technology names, have shown strong gains this year, helping support the ETF’s overall results.
Broad Sector Diversification
The ETF spreads its investments across many sectors such as health care, technology, industrials, and consumer stocks, which can help reduce the impact of weakness in any single industry.
Negative Factors
High Geographic Concentration in Hong Kong
Most of the fund’s assets are tied to Hong Kong-listed companies, which increases exposure to local economic, regulatory, and political risks.
Recent Short-Term Volatility
The ETF has had a weak three-month stretch despite a stronger one-month rebound, suggesting that returns can be bumpy over shorter periods.
Relatively High Expense Ratio
The fund’s ongoing fee is on the higher side for an ETF, which can gradually eat into long-term returns compared with lower-cost options.
ECNS vs. SPDR S&P 500 ETF (SPY)
AUM63.62M
RegionAsia-Pacific
Expense Ratio0.59%
Beta0.75
IssueriShares
Inception DateSep 28, 2010
Dividend Yield6.7%
Asset ClassEquity
Index TrackedMSCI China Small Cap
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,513
30 Day Avg. Volume17,480
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
52.52Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering236
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ECNS Summary
The iShares MSCI China Small-Cap ETF (ECNS) tracks the MSCI China Small Cap index, focusing on smaller companies in China and Hong Kong across many sectors like health care, technology, and industrials. It holds lesser-known but growing businesses such as Minth Group and Kingsoft Cloud. Someone might invest in this ETF to seek long-term growth and diversification by spreading money across many small, fast-growing Chinese companies instead of picking individual stocks. A key risk is that small-cap Chinese stocks can be very volatile and are sensitive to changes in China’s economy, regulations, and overall market conditions.
How much will it cost me?The iShares MSCI China Small-Cap ETF (ECNS) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because the fund is actively managed to focus on small-cap stocks in China, which requires more research and management compared to passively managed funds. It’s designed for investors seeking growth opportunities in a niche market.
What would affect this ETF?The iShares MSCI China Small-Cap ETF (ECNS) could benefit from China's economic growth and government support for innovation, especially in sectors like healthcare and technology, which make up a significant portion of its holdings. However, risks include potential regulatory changes in China, global economic uncertainty, and the volatility of small-cap stocks, which are more sensitive to market fluctuations. Investors should also consider how geopolitical tensions or shifts in trade policies might impact the ETF's performance.
ECNS Top 10 Holdings
ECNS is leaning heavily into China’s small-cap health care and industrial names, with Kingboard Holdings acting as a key engine of recent gains while Dongyue Group adds a steadier, if more subdued, lift. On the flip side, consumer and tech names like Meitu and Atour Lifestyle have been losing steam, quietly tugging on performance. Zai Lab and China Everbright show more mixed signals, reflecting the choppy backdrop for Chinese small caps. With all its bets placed in China, the fund’s fortunes are tightly tied to that market’s next chapter.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kingboard Holdings | 6.22% | $3.93M | HK$140.31B | 395.87% | 69 Neutral | |
| Dongyue Group Limited | 2.09% | $1.32M | HK$34.91B | 135.16% | 62 Neutral | |
| Minth Group | 1.63% | $1.03M | HK$34.60B | 109.13% | 71 Outperform | |
| China Everbright | 1.40% | $884.04K | HK$29.42B | 17.88% | 66 Neutral | |
| Zai Lab Ltd | 1.37% | $863.42K | HK$16.25B | -51.64% | 42 Neutral | |
| China Conch Venture Holdings | 1.32% | $832.51K | HK$18.51B | 0.00% | 67 Neutral | |
| Keymed Biosciences, Inc. | 1.23% | $774.85K | HK$16.14B | 22.86% | 41 Neutral | |
| Meitu | 1.14% | $721.42K | HK$20.09B | -38.65% | 66 Neutral | |
| TCL Electronics Holdings | 1.14% | $717.74K | HK$34.06B | 22.06% | 66 Neutral | |
| Atour Lifestyle Holdings | 1.13% | $711.24K | $4.58B | 8.54% | 75 Outperform |
ECNS Technical Analysis
Negative
―
Price Trends
31.21
Negative
32.48
Negative
33.42
Negative
Market Momentum
-0.85
Positive
31.73
Neutral
19.84
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ECNS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 29.39, equal to the 50-day MA of 31.21, and equal to the 200-day MA of 33.42, indicating a bearish trend. The MACD of -0.85 indicates Positive momentum. The RSI at 31.73 is Neutral, neither overbought nor oversold. The STOCH value of 19.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ECNS.
ECNS Peer Comparison
Comparison Results
Performance Comparison
ECNS
iShares MSCI China Small-Cap ETF
28.36
-1.62
-5.40%
FXI
iShares China Large-Cap ETF
―
―
―
PGJ
Invesco Golden Dragon China Etf
―
―
―
FLAU
Franklin FTSE Australia ETF
―
―
―
FCA
First Trust China AlphaDEX Fund
―
―
―
MJSC
MUFG Japan Small Cap Active ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents